2.5 Serum and BAL antibody ELISA SARS-CoV-2 RBD203-N1 (RBD)-specific antibodies in serum ... Serum-treated plates were washed then probed with 25 μL of goat anti-mouse IgG, IgG1, or IgG2a horseradish ...

The non-structural protein nsp16 of SARS-CoV-2 was identified that can be degraded through the ... Cell lysates were subjected to immunoprecipitation with anti-UBR5 or IgG antibody. (C-D). Hela cells ...

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...

IgG seropositivity at the beginning of years ... test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or a localized cause of fever (e.g., cellulitis). When appropriate, a study ...

Some 23% of people infected with SARS-CoV-2 between 2021 and 2023 developed long COVID, and in more than half of them the symptoms persisted for two years. These are the main conclusions of a study ...

In 298 residents (median age 86 years, range 75–101), anti-SARS-CoV-2 rector binding IgG antibody (anti-RBD-IgG) concentrations were low and inversely correlated with age (mean 51.60 BAU/ml). We ...

However, without any previous coughing, fever symptom, her antigen swab of SARS-CoV-2 IgG/IgM showed non-reactive result and her chest X-ray represented cardiomegaly with lung oedema appearance ...